Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 203 clinical trials
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis (FREXALT)

  • The assessment of scheduled visits will include 1 common end of study [EOS] visit and 3 follow-up visits) with a visit frequency of every 4 weeks for the first 6 months and then every 3 months.
    • ul>

    • 0 views
    • 24 Feb, 2025
    A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

  • To evaluate the effect of venglustat on the lens by ophthalmological examination (Stages 1 and 2).
    • ul>

    urine osmolality
    renal disease
    antihypertensive therapy
    ophthalmological examination
    human chorionic gonadotropin
    • 0 views
    • 19 Feb, 2024
    • 81 locations
    Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

    Primary Objective:

    <ul>
  • To describe the safety profile of the SP MenB vaccine formulations and the 2 licensed MenB comparator vaccines in healthy adults, adolescents, toddlers and infants, when administered alone (Stages 1-4) or concomitantly with MenQuadfiTM (MenACYW conjugate vaccine) (for Stages 2-4 only), and with age-appropriated routine pediatric vaccines …

    Accepts healthy volunteers
    • 0 views
    • 19 Feb, 2024
    • 22 locations
    Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

    Primary Objective:
    <ul>
  • To describe the safety profile of the SP MenB vaccine formulations and the 2 licensed MenB comparator vaccines in healthy adults, adolescents, toddlers and infants, when administered alone (Stages 1-4) or concomitantly with MenQuadfiTM (MenACYW conjugate vaccine) (for Stages 2-4 only), and with age-appropriated routine pediatric vaccines …

    Accepts healthy volunteers
    • 0 views
    • 19 Feb, 2024
    • 21 locations
    Genetic Characteristics of Metastatic Breast Cancer Patients

  • At disease progression after 1st line treatment for MBC, blood sample (20cc) will be obtained (tissue; optional)
    • ul>

    (2) WES, RNASeq, ctDNA, Exosome

    <ul>
  • We will analyze genomic characteritics using WES, RNASeq, ctDNA, Exosome.
    • ul>

    breast cancer
    cancer
    stage iv breast cancer
    • 0 views
    • 19 Feb, 2024
    Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

    ul>

    Secondary Objectives:

    <ul>
  • Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates.

    diphenhydramine
    kidney transplant
    nephropathy
    isatuximab
    sar650984
    • 0 views
    • 19 Feb, 2024
    • 2 locations
    MTD Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors

    ul>

    • 0 views
    • 19 Feb, 2024
    Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor Copanlisib Given in Combination With the Immunotherapeutic Agents Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma

    Patients with relapsed or refractory follicular or marginal zone lymphoma who have received at least one prior line of therapy will receive

    <ul>
  • Copanlisib IV: day 1, 8, 15 every 28 days
  • Nivolumab IV: Cycle 1 days 1 and 15; then day 1 only
  • Rituximab IV: Cycle 1 days …

    copanlisib
    heart failure
    stem cell transplant
    cyp3a4 inducers
    cardiac arrhythmia
    • 0 views
    • 19 Feb, 2024
    Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19

    Objectives :

    Primary objective:

    To describe the lung ultrasound lesions in pregnant women in case of suspected or confirmed COVID-19

    Secondary objectives:

    <ul>
  • To compare the lung ultrasound lesions with chest Computed Tomography -scanner (CT-Scan) lesions
  • To evaluate the performances of …

    • 0 views
    • 19 Feb, 2024
    A Multinational Randomized Double-blind Placebo-controlled Study to Assess the Efficacy Pharmacodynamics Pharmacokinetics and Safety of Venglustat in Late-onset GM2

    Primary Objectives:

    Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period

    Secondary population (participants with juvenile/adolescent late-onset GM2 gangliosidosis, GM1 gangliosidosis, saposin C deficiency, sialidosis type 1 or …

    • 0 views
    • 19 Feb, 2024
    • 2 locations